| Artículo | 2024 |
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
|
AIDS Patient Care and ST Ds |
| Artículo | 2024 |
Detección de la hepatitis C en los servicios de urgencias hospitalarios
|
EMERGENCIAS |
| Artículo | 2024 |
Early Detection of Cancer and Precancerous Lesions in Persons With Human Immunodeficiency Virus (HIV) Through a Comprehensive Cancer Screening Protocol
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2024 |
Impact of Nonalcoholic Fatty Liver Disease on the Survival of People Living With HIV
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| Artículo | 2024 |
Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile
|
OPEN FORUM INFECTIOUS DISEASES |
| Artículo | 2024 |
Low rate of vaccination and risk of incident hepatitis A among HIV-infected men who have sex with men in Seville, Southern Spain
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2024 |
The absence of seroconversion after exposition to hepatitis C virus is not related to KIR-HLA genotype combinations (GEHEP-012 study)
|
ANTIVIRAL RESEARCH |
| Artículo | 2023 |
Burden of significant liver damage in people living with HIV after microelimination of the hepatitis C virus.
|
JOURNAL OF INFECTION |
| Corrección | 2023 |
Correction: Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection (Trials, (2021), 22, 1, (851), 10.1186/s13063-021-05777-6)
|
TRIALS |
| Artículo | 2023 |
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2023 |
Hepatic steatosis after switching to integrase inhibitor-based regimens does not parallel short-term weight gain
|
AIDS |
| Artículo | 2023 |
Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide.
|
OPEN FORUM INFECTIOUS DISEASES |
| Artículo | 2023 |
Incidence of Anal Cancer and Related Risk Factors in HIV-Infected Patients Enrolled in the National Prospective Spanish Cohort CoRIS
|
DISEASES OF THE COLON & RECTUM |
| Artículo | 2023 |
Poor increase on HAV vaccination coverage among people living with HIV after an immunization-based intervention
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2023 |
Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV-infected patients.
|
LIVER INTERNATIONAL |
| Artículo | 2023 |
Reduced neutralizing antibody response to SARS-CoV-2 vaccine booster dose in people living with HIV with severe immunosuppression
|
JOURNAL OF MEDICAL VIROLOGY |
| Artículo | 2023 |
Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Letter | 2023 |
Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2
|
Enfermedades infecciosas y microbiología clínica |
| Letter | 2023 |
Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2023 |
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2022 |
Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis
|
Scientific reports |
| Artículo | 2022 |
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)
|
OPEN FORUM INFECTIOUS DISEASES |
| Artículo | 2022 |
Discovering HIV related information by means of association rules and machine learning
|
Scientific reports |
| Artículo | 2022 |
High efficacy of Glecaprevir/Pibrentasvir for HCV-Infected individuals with active drug use.
|
JOURNAL OF INFECTION |
| Artículo | 2022 |
Incidence of and factors associated with SARS-CoV-2 infection among people living with HIV in Southern Spain after one year of pandemic.
|
TRANSBOUNDARY AND EMERGING DISEASES |
| Letter | 2022 |
Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV.
|
CLINICAL MICROBIOLOGY AND INFECTION |
| Artículo | 2022 |
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|
NATURE GENETICS |
| Artículo | 2022 |
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: a Spanish nationwide cohort
|
HIV MEDICINE |
| Artículo | 2022 |
Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV
|
CLINICAL MICROBIOLOGY AND INFECTION |
| Nota | 2022 |
Ten steps to eliminating hepatitis C in hospitals
|
Nature Reviews Gastroenterology and Hepatology |
| Artículo | 2022 |
Tenofovir disoproxil fumarate/emtricitabine and severity of coronavirus disease 2019 in people with HIV infection
|
AIDS |
| Artículo | 2021 |
A genome-wide association study on liver stiffness changes during hepatitis c virus infection cure
|
Diagnostics |
| Artículo | 2021 |
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
|
NATURE COMMUNICATIONS |
| Artículo | 2021 |
COVID-19 in hospitalized HIV-positive and HIV-negative patients: a matched study
|
HIV MEDICINE |
| Artículo | 2021 |
Cryptococcal infection in HIV-infected patients with CD4+ T-cell counts under 100/μL diagnosed in a high-income country: a multicentre cohort study
|
CLINICAL MICROBIOLOGY AND INFECTION |
| Artículo | 2021 |
Drug–drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain
|
Scientific reports |
| Artículo | 2021 |
Exploring and understanding HCV patient journeys- HEPCARE Europe project
|
BMC INFECTIOUS DISEASES |
| Artículo | 2021 |
Genomic characterization of host factors related to SARS-CoV-2 infection in people with dementia and control populations: the GR@ACE/DEGESCO study
|
Journal of personalized medicine |
| Artículo | 2021 |
HIV infection is associated with lower risk of hepatocellular carcinoma after sustained virological response to direct-acting antivirals in hepatitis C infected-patients with advanced fibrosis
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2021 |
How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort
|
BMC WOMENS HEALTH |
| Artículo | 2021 |
Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection
|
TRIALS |
| Artículo | 2021 |
Impact of recent drug use on the efficacy of Elbasvir/Grazoprevir for HCV-infected people on opioid agonist therapy.
|
JOURNAL OF VIRAL HEPATITIS |
| Artículo | 2021 |
Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain
|
HIV MEDICINE |
| Artículo | 2021 |
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01
|
EClinicalMedicine |
| Artículo | 2021 |
Kinetics of emergence of liver complications in HCV-infected patients and advanced fibrosis, with and without HIV-coinfection, after SVR.
|
AIDS |
| Artículo | 2021 |
Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues.
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2021 |
Liver stiffness-based strategies predict absence of variceal bleeding in cirrhotic hepatitis C virus-infected patients with and without human immunodeficiency virus coinfection after sustained virological response
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2021 |
Long runs of homozygosity are associated with Alzheimer’s disease
|
TRANSLATIONAL PSYCHIATRY |
| Letter | 2021 |
Progression to hepatitis C virus micro-elimination in people living with HIV in Spain
|
CLINICAL MICROBIOLOGY AND INFECTION |
| Artículo | 2021 |
Reply to Giannini et al.
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2021 |
Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy.
|
PLOS ONE |
| Artículo | 2020 |
Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study
|
AIDS RESEARCH AND THERAPY |
| Artículo | 2020 |
Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users
|
Enfermedades infecciosas y microbiología clínica |
| Otros | 2020 |
Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2020 |
Hepatitis E 3ra genotype infection in people living with HIV in Spain
|
FRONTIERS IN MICROBIOLOGY |
| Artículo | 2020 |
HEPCARE EUROPE- A case study of a service innovation project aiming at improving the elimination of HCV in vulnerable populations in four European cities
|
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES |
| Artículo | 2020 |
HepCare Europe—A service innovation project. HepCheck: Characteristics of the patient population with active infection as defined by HCV RNA
|
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES |
| Artículo | 2020 |
High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment
|
Scientific reports |
| Artículo | 2020 |
Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients
|
AIDS |
| Artículo | 2020 |
Liver stiffness at the time of sustained virological response predicts the clinical outcome in people living with human immunodeficiency virus and hepatitis C virus with advanced fibrosis treated with direct-acting antivirals
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2020 |
Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2020 |
Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection
|
Scientific reports |
| Artículo | 2020 |
What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis
|
BMC INFECTIOUS DISEASES |
| Artículo | 2019 |
A genome-wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study)
|
LIVER INTERNATIONAL |
| Artículo | 2019 |
Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients
|
JOURNAL OF VIRAL HEPATITIS |
| Artículo | 2019 |
Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection
|
Scientific reports |
| Artículo | 2019 |
Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ACE project
|
Alzheimer's & Dementia |
| Artículo | 2019 |
HepCare Europe: a service innovation project. HepCheck: enhancing HCV identification and linkage to care for vulnerable populations through intensified outreach screening. A prospective multisite feasibility study
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2019 |
Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks
|
JOURNAL OF INFECTION |
| Artículo | 2019 |
HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals
|
AIDS |
| Artículo | 2019 |
Integrating hepatitis C care for at-risk groups (HepLink): baseline data from a multicentre feasibility study in primary and community care
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2019 |
Integrating primary and secondary care to optimize hepatitis C treatment: development and evaluation of a multidisciplinary educational Masterclass series
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2019 |
Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients
|
AIDS |
| Artículo | 2019 |
MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection
|
JOURNAL OF CLINICAL MEDICINE |
| Artículo | 2019 |
Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients
|
HIV MEDICINE |
| Artículo | 2019 |
Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort
|
PLOS ONE |
| Artículo | 2019 |
Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2019 |
Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection
|
JOURNAL OF VIRAL HEPATITIS |
| Artículo | 2019 |
The simplification of the diagnosis process of chronic hepatitis C is cost-effective strategy
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2018 |
Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients
|
JOURNAL OF VIRAL HEPATITIS |
| Artículo | 2018 |
Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life
|
Scientific reports |
| Artículo | 2018 |
Guía de tratamiento de la infección por virus de la hepatitis C. Asociación Española para el Estudio del Hígado (AEEH)
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Artículo | 2018 |
Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients
|
AIDS |
| Artículo | 2018 |
Hepcare Europe - bridging the gap in the treatment of hepatitis C: study protocol
|
Expert Review of Gastroenterology and Hepatology |
| Artículo | 2018 |
Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort
|
JOURNAL OF VIRAL HEPATITIS |
| Artículo | 2018 |
Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice
|
HIV CLINICAL TRIALS |
| Artículo | 2018 |
Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2017 |
Changes in liver steatosis after switching from efavirenz to raltegravir among human immunodeficiency virus-infected patients with nonalcoholic fatty liver disease
|
CLINICAL INFECTIOUS DISEASES |
| Resumen congreso | 2017 |
Early emergence of opportunistic infections after starting direct acting antiviral drugs in HIV/HCV coinfected patients
|
HEPATOLOGY |
| Artículo | 2017 |
Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients
|
HIV MEDICINE |
| Artículo | 2017 |
High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice
|
HIV MEDICINE |
| Artículo | 2017 |
HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy
|
PHARMACOGENOMICS JOURNAL |
| Letter | 2017 |
HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients
|
PHARMACOGENOMICS JOURNAL |
| Artículo | 2017 |
Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Artículo | 2017 |
Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis
|
AIDS |
| Letter | 2017 |
Low incidence of acute hepatitis C virus infection among Southern Spanish HIV-infected individuals
|
JOURNAL OF INFECTION |
| Revisión | 2017 |
Non-Alcoholic Fatty Liver Disease in HIV Infection
|
AIDS REVIEWS |
| Artículo | 2017 |
Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection
|
CLINICAL MICROBIOLOGY AND INFECTION |
| Artículo | 2016 |
Changes in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV-infected patients
|
HIV MEDICINE |
| Artículo | 2016 |
Changes in the response to treatment against chronic hepatitis C between 1999 and 2015: data from a prospective cohort
|
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
| Artículo | 2016 |
Common haplotypes in CD209 promoter and susceptibility to HIV-1 infection in intravenous drug users
|
INFECTION GENETICS AND EVOLUTION |
| Revisión | 2016 |
HCV epidemiology in high-risk groups and the risk of reinfection
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2016 |
Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study
|
PLOS ONE |
| Artículo | 2016 |
MicroRNA profile in CD8+T-Lymphocytes from HIV-infected individuals: relationship with antiviral immune response and disease progression
|
PLOS ONE |
| Artículo | 2016 |
No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000-2014
|
BMC INFECTIOUS DISEASES |
| Artículo | 2016 |
The PNPLA3 genetic variant rs738409 influences the progression to cirrhosis in HIV/Hepatitis C virus coinfected patients
|
PLOS ONE |
| Artículo | 2015 |
Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection
|
Genes & Immunity |
| Artículo | 2015 |
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Artículo | 2015 |
Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C
|
JOURNAL OF INFECTION |
| Artículo | 2015 |
High prevalence of antibodies against hepatitis E virus in HIV-infected patients with unexplained liver disease
|
Enfermedades infecciosas y microbiología clínica |
| Letter | 2015 |
IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection
|
AIDS |
| Artículo | 2015 |
Impact of genetic polymorphisms associated with nonalcoholic fatty liver disease on HIV-infected individuals
|
AIDS |
| Artículo | 2015 |
Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Artículo | 2015 |
Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection
|
PLOS ONE |
| Artículo | 2015 |
Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term
|
HEPATOLOGY |
| Artículo | 2015 |
Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis
|
BMC INFECTIOUS DISEASES |
| Artículo | 2014 |
A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers
|
LIVER INTERNATIONAL |
| Artículo | 2014 |
Core amino acid variation at position 110 is associated with sustained virological response in Caucasian patients with chronic hepatitis C virus 1b infection
|
ARCHIVES OF VIROLOGY |
| Artículo | 2014 |
Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting
|
HIV MEDICINE |
| Artículo | 2014 |
IFNL4 ss469415590 Variant Shows Similar Performance to rs12979860 as Predictor of Response to Treatment against Hepatitis C Virus Genotype 1 or 4 in Caucasians
|
PLOS ONE |
| Artículo | 2014 |
Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients
|
AIDS |
| Artículo | 2014 |
Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004-2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions
|
PLOS ONE |
| Revisión | 2014 |
Latest pharmacotherapy options for treating hepatitis C in HIV-infected patients
|
EXPERT OPINION ON PHARMACOTHERAPY |
| Artículo | 2014 |
Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients
|
AIDS |
| Artículo | 2014 |
Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatment
|
JOURNAL OF CLINICAL MICROBIOLOGY |
| Artículo | 2014 |
Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy
|
JOURNAL OF INFECTION |
| Artículo | 2013 |
A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2013 |
Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBV
|
INFECTION |
| Artículo | 2013 |
Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/Hepatitis C virus-coinfected patients with compensated cirrhosis
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2013 |
Chronic Hepatitis E in HIV Patients: Rapid Progression to Cirrhosis and Response to Oral Ribavirin
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2013 |
Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Artículo | 2013 |
Endoplasmic reticulum aminopeptidase 2 haplotypes play a role in modulating susceptibility to HIV infection
|
AIDS |
| Artículo | 2013 |
Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV
|
PLOS ONE |
| Artículo | 2013 |
Interobserver concordance in controlled attenuation parameter measurement, a novel tool for the assessment of hepatic steatosis on the basis of transient elastography
|
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
| Artículo | 2013 |
Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients
|
AIDS |
| Artículo | 2013 |
Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response
|
JOURNAL OF INFECTION |
| Artículo | 2013 |
Risk of Liver Decompensation Among HIV/Hepatitis C Virus-Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2013 |
Safety and efficacy of telaprevir in patients with HIV and hepatitis C virus coinfection
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2013 |
Sustained virological response to pegylated interferon plus ribavirin leads to normalization of liver stiffness in hepatitis C virus-infected patients
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2013 |
Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection
|
AIDS |
| Artículo | 2012 |
A Common Polymorphism in TLR3 Confers Natural Resistance to HIV-1 Infection
|
JOURNAL OF IMMUNOLOGY |
| Artículo | 2012 |
Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Artículo | 2012 |
Genetic variability at the TREX1 locus is not associated with natural resistance to HIV-1 infection
|
AIDS |
| Artículo | 2012 |
Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis
|
JOURNAL OF INFECTION |
| Artículo | 2012 |
Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients
|
HEPATOLOGY |
| Artículo | 2012 |
Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients
|
AIDS |
| Artículo | 2012 |
HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection
|
ANTIVIRAL RESEARCH |
| Artículo | 2012 |
Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapy
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Letter | 2012 |
Liver stiffness correlates with Child-Pugh-Turcotte and MELD scores in HIV/hepatitis C virus-coinfected patients with cirrhosis
|
LIVER INTERNATIONAL |
| Artículo | 2012 |
Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis
|
HEPATOLOGY |
| Artículo | 2012 |
Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients
|
HIV CLINICAL TRIALS |
| Reseña | 2012 |
Low prevalence of occult HBV infection among HIV-infected patients in southern Spain
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2012 |
No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patients
|
ANTIVIRAL RESEARCH |
| Artículo | 2012 |
Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2012 |
Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus-Coinfected Patients With Compensated Liver Cirrhosis
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2011 |
Combined use of aspartate aminotransferase, platelet count and matrix metalloproteinase 2 measurements to predict liver fibrosis in HIV/hepatitis C virus-coinfected patients
|
HIV MEDICINE |
| Artículo | 2011 |
Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype
|
HIV MEDICINE |
| Artículo | 2011 |
Host genetics
|
CURRENT OPINION IN HIV AND AIDS |
| Artículo | 2011 |
Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV/HCV co-infected patients
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2011 |
Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2011 |
Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2011 |
Liver toxicity of antiretroviral combinations including Fosamprenavir plus Ritonavir 1400/100mg once daily in HIV/Hepatitis C virus-coinfected patients
|
AIDS Patient Care and ST Ds |
| Artículo | 2011 |
Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patients
|
AIDS |
| Artículo | 2011 |
Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2010 |
Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2010 |
Haart and the liver: friend or foe?
|
EUROPEAN JOURNAL OF MEDICAL RESEARCH |
| Artículo | 2010 |
Infección por el virus de la inmunodeficiencia humana en diferentes grupos de edad: implicaciones potenciales para la prevención. Cohorte CoRIS, España, 2004-2008
|
MEDICINA CLINICA |
| Artículo | 2010 |
Interobserver concordance in the assessment of liver fibrosis in HIV/HCV-coinfected patients using transient elastometry
|
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
| Artículo | 2010 |
Modeling the Probability of Sustained Virological Response to Therapy with Pegylated Interferon plus Ribavirin in Patients Coinfected with Hepatitis C Virus and HIV
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2010 |
Prediction of Response to Pegylated Interferon plus Ribavirin by IL28B Gene Variation in Patients Coinfected with HIV and Hepatitis C Virus
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2010 |
Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients
|
JOURNAL OF VIRAL HEPATITIS |
| Artículo | 2010 |
Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine
|
ANTIVIRAL THERAPY |
| Artículo | 2010 |
Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practice
|
HIV MEDICINE |
| Revisión | 2009 |
A review of current anti-HCV treatment regimens and possible future strategies
|
EXPERT OPINION ON PHARMACOTHERAPY |
| Artículo | 2009 |
Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus-Coinfected Patients with Advanced Immunosuppression
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2009 |
Fast Fibrosis Progression Between Repeated Liver Biopsies in Patients Coinfected with Human Immunodeficiency Virus/Hepatitis C Virus
|
HEPATOLOGY |
| Artículo | 2009 |
Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2009 |
Impact of Observer Experience on the Reproducibility of Transient Elastometry in HIV/HCV Co-infected Patients
|
HIV CLINICAL TRIALS |
| Artículo | 2009 |
Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients
|
GUT |
| Artículo | 2009 |
Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2009 |
Liver Stiffness as a Predictor of Esophageal Varices Requiring Therapy in HIV/Hepatitis C Virus-Coinfected Patients With Cirrhosis
|
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES |
| Artículo | 2009 |
Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2009 |
Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation
|
ANTIVIRAL THERAPY |
| Artículo | 2008 |
Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2008 |
Changes in liver-related hospital admissions and hospital mortality among HIV-infected patients (1998 to 2005)
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2008 |
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2008 |
High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack
|
LIVER INTERNATIONAL |
| Artículo | 2008 |
Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2008 |
Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users
|
JOURNAL OF INFECTIOUS DISEASES |
| Artículo | 2007 |
Clinical progression of hepatitis C virus - Related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active Antiretroviral therapy
|
HEPATOLOGY |
| Artículo | 2007 |
Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2007 |
Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients
|
ANTIVIRAL THERAPY |
| Artículo | 2007 |
Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients
|
ANTIVIRAL THERAPY |
| Artículo | 2007 |
The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2006 |
Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C
|
ANTIVIRAL THERAPY |
| Artículo | 2006 |
Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis
|
AIDS RESEARCH AND HUMAN RETROVIRUSES |
| Artículo | 2006 |
Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy
|
ANTIVIRAL THERAPY |
| Artículo | 2006 |
Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2006 |
Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients
|
JOURNAL OF VIRAL HEPATITIS |
| Artículo | 2006 |
Low incidence of severe liver events in HIV patients with and without hepatitis C or B coinfection receiving lopinavir/ritonavir
|
HIV CLINICAL TRIALS |
| Artículo | 2006 |
Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes
|
GUT |
| Artículo | 2006 |
Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease
|
AIDS |
| Artículo | 2006 |
Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients
|
JOURNAL OF CLINICAL MICROBIOLOGY |
| Letter | 2005 |
Antiretroviral therapy and liver fibrosis in HIV-infected patients with chronic hepatitis C
|
HEPATOLOGY |
| Artículo | 2005 |
Increased hepatocyte Fas expression and apoptosis in HIV and hepatitis C virus coinfection
|
JOURNAL OF INFECTIOUS DISEASES |
| Artículo | 2005 |
Prevalencia de anticuerpos séricos frente a Bartonella spp. en una población sana del área sur de la provincia de Sevilla
|
REVISTA CLINICA ESPANOLA |
| Artículo | 2005 |
Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapy
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2005 |
Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy
|
AIDS RESEARCH AND HUMAN RETROVIRUSES |
| Artículo | 2005 |
Transient rebounds of hiv plasma vieremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapy
|
JOURNAL OF INFECTION |
| Artículo | 2004 |
Bilateral enophthalmos as a manifestation of HIV infection-related lipoatrophy
|
HIV MEDICINE |
| Artículo | 2004 |
Detection of Leishmania infantum kinetoplast DNA in peripheral blood from asymptomatic individuals at risk for parenterally transmitted infections: Relationship between polymerase chain reaction results and other Leishmania infection markers
|
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE |
| Artículo | 2004 |
Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine
|
AIDS |
| Artículo | 2004 |
Frequency of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy
|
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE |
| Artículo | 2004 |
Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment
|
ANTIVIRAL THERAPY |
| Letter | 2004 |
Prevalence of non-significant liver fibrosis and rate of fibrosis progression in HIV/hepatitis C virus-co-infected patients: still a role for liver biopsy?
|
AIDS |
| Artículo | 2003 |
Bone involvement and abcess formation by neutrophil-rich CD30+anaplastic large-cell lymphoma mimicking skeletal infection in an AIDS patient
|
JOURNAL OF INFECTION |
| Artículo | 2003 |
Dinámica de anticuerpos IgG frente a Bartonella spp. en la enfermedad por arañazo de gato y en pacientes asintomáticos infectados por el virus de la inmunodeficiencia humana
|
MEDICINA CLINICA |
| Artículo | 2003 |
Impaired recovery of CD4+cell counts following highly active antiretroviral therapy in drug-naive patients coinfected with human immunodeficiency virus and hepatitis C virus
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Artículo | 2003 |
Influence of hepatitis C virus coinfection on failure of HIV-infected patients receiving highly active antiretroviral therapy to achieve normal serum beta 2microglobulin levels
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Capítulo | 2003 |
Leishmaniasis e infección por el VIH
|
La infección por el VIH: guía práctica |
| Artículo | 2003 |
Necrotizing granulomatous vasculitis in advanced HIV infection
|
JOURNAL OF INFECTION |
| Artículo | 2003 |
Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients
|
HIV CLINICAL TRIALS |
| Artículo | 2002 |
Efecto del tratamiento antirretroviral de gran actividad sobre la forma de presentación del sida definido por episodios clínicos
|
MEDICINA CLINICA |
| Artículo | 2002 |
Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy
|
JOURNAL OF CLINICAL MICROBIOLOGY |
| Artículo | 2002 |
Leishmania infantum (Protozoa, Kinetoplastida): transmission from infected patients to experimental animal under conditions that simulate needle-sharing
|
EXPERIMENTAL PARASITOLOGY |
| Letter | 2002 |
Leishmania spp infection in injecting drug users
|
LANCET |
| Artículo | 2002 |
Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Artículo | 2002 |
Prevalencia de seropositividad para Bartonella spp. en pacientes adictos a drogas por vía parenteral infectados y no infectados por el virus de la inmunodeficiencia humana
|
MEDICINA CLINICA |
| Artículo | 2002 |
The high sensitivity of a PCR-ELISA in the diagnosis of cutaneous and visceral leishmaniasis caused by Leishmania infantum
|
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY |
| Artículo | 2002 |
Transient rebounds of low-level viraemia among HIV-infected patients under HAART are not associated with virological or immunological failure
|
ANTIVIRAL THERAPY |
| Artículo | 2001 |
Evidence of increased risk for Leishmania infantum infection among HIV-seronegative intravenous drug users from southern Spain
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Editorial | 2001 |
False-positive results of leishmanin skin test due to phenol-containing diluent
|
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE |
| Artículo | 2001 |
HIV-1 plasma viremia not increased in patients receiving highly active antiretroviral therapy after influenza vaccination
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Letter | 2001 |
HIV-1 progression in hepatitis-C-infected drug users
|
LANCET |
| Letter | 2001 |
HIV-1 progression in hepatitis-C-infected drug users [3] (multiple letters)
|
LANCET |
| Artículo | 2001 |
Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2001 |
Low levels of HIV-1 plasma viral load in patients infected with HIV-1 subtype B and advanced immunosuppression
|
JOURNAL OF INFECTION |
| Artículo | 2001 |
Minimal liver injury in chronic hepatitis C virus infection is associated with low levels of soluble TNF-alpha/Fas receptors and acquisition in childhood
|
Liver |
| Artículo | 2001 |
Structural normalization of the lymphoid tissue in asymptomatic HIV-infected patients after 48 weeks of potent antiretroviral therapy
|
AIDS |
| Artículo | 2001 |
Usefulness of route of transmission, absolute CD8+ T-cell counts, and levels of serum tumor necrosis factor alpha as predictors of survival of HIV-1-infected patients with very low CD4+ T-cell counts
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Artículo | 2000 |
CD4(+) and CD8(+) T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients
|
CLINICAL AND EXPERIMENTAL IMMUNOLOGY |
| Artículo | 1999 |
Colestasis disociada en pacientes infectados por el VIH-1. Prevalencia y valor diagnóstico de la biopsia hepática
|
REVISTA CLINICA ESPANOLA |
| Artículo | 1999 |
El impacto clínico de la leishmaniasis visceral sintomática sobre la infección por el VIH-1
|
MEDICINA CLINICA |
| Artículo | 1999 |
High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients
|
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE |
| Letter | 1999 |
Rapid progression to liver cirrhosis of toxic hepatitis due to ebrotidine
|
JOURNAL OF HEPATOLOGY |
| Artículo | 1999 |
Reduction of immune system activation in HIV-1-infected patients undergoing highly active antiretroviral therapy
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Letter | 1999 |
The clinical impact of symptomatic visceral leishmaniasis on HIV-1 infection
|
MEDICINA CLINICA |
| Letter | 1999 |
The clinical impact of symptomatic visceral leishmaniasis on the outcome of HIV-1 infection
|
MEDICINA CLINICA |
| Artículo | 1998 |
El tratamiento antirretroviral con análogos de nucleósidos no disminuye la viremia del virus de la hepatitis C en pacientes infectados por el virus de la inmunodeficiencia humana tipo 1
|
MEDICINA CLINICA |
| Artículo | 1998 |
Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Artículo | 1998 |
Influencia de la actuación médica sobre la forma de presentación del sida definido por episodios clínicos
|
MEDICINA CLINICA |
| Artículo | 1998 |
Low sensitivity of peripheral blood smear for diagnosis of subclinical visceral leishmaniasis in human immunodeficiency virus type 1-infected patients
|
JOURNAL OF CLINICAL MICROBIOLOGY |
| Artículo | 1998 |
Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain
|
JOURNAL OF CLINICAL MICROBIOLOGY |
| Artículo | 1998 |
Regression of invasive AIDS-related Kaposi's sarcoma following antiretroviral therapy
|
CLINICAL INFECTIOUS DISEASES |
| Letter | 1997 |
Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection.
|
AIDS |
| Artículo | 1997 |
Unexpected high prevalence of hepatitis C virus genotype 4 in southern Spain
|
JOURNAL OF HEPATOLOGY |
| Letter | 1996 |
Frequency of subclinical visceral leishmaniasis in HIV-1-infected patients in Spain
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Editorial | 1996 |
Kala-azar in HIV infection: The tip of the iceberg?
|
MEDICINA CLINICA |
| Artículo | 1996 |
Specificity of a commercial indirect immunofluorescence technique in the diagnosis of visceral leishmaniasis in patients infected with HIV-1
|
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE |
| Letter | 1995 |
Granulomatous pneumonitis: A clinical manifestation and atypical pathology of pneumocystosis in AIDS
|
MEDICINA CLINICA |
| Letter | 1995 |
Granulomatous pneumonitis: A clinical manifestation and atypical pathology of pneumocystosis in AIDS [1]
|
MEDICINA CLINICA |
